Welcome to our dedicated page for MICROCHIP TECHNOLOGY SEC filings (Ticker: MCHP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Microchip Technology Inc. filings document operating results, material events, governance matters, and capital-structure disclosures for a public semiconductor company. Form 8-K reports include quarterly and annual results, financial-condition exhibits, material-event disclosures, material agreements, and securities information for common stock and depositary shares representing interests in 7.50% Series A Mandatory Convertible Preferred Stock.
Proxy and annual meeting filings cover board elections, auditor ratification, executive compensation, shareholder voting matters, and related governance disclosures. The company’s regulatory record also provides formal disclosure on security listings, stockholder approvals, and the corporate actions and risk topics associated with its semiconductor product portfolio and public-company obligations.
Matthew W. Chapman, a director of Microchip Technology Inc. (MCHP), reported a sale of 10,000 shares of the issuer's common stock on 08/25/2025 at a reported price of $68.255 per share. After the sale, Mr. Chapman beneficially owned 30,665 shares, held directly. The Form 4 indicates no derivative transactions and was signed on behalf of the reporting person by an attorney-in-fact on 08/27/2025.
A trust associated with Microchip Technology Senior VP and CFO James Eric Bjornholt sold 3,053 and 4,303 shares of common stock on August 25, 2025 at $69.14 and $68.42 per share, respectively, totaling 7,356 shares. The sales were executed under a Rule 10b5-1 trading plan adopted on May 23, 2025. After these transactions, the trust continues to hold 30,010 shares indirectly.
Microchip Technology, Inc. (MCHP) filed a Form 144 notifying a proposed sale of 10,000 shares of common stock through Merrill Lynch at 2049 Century Park East, Los Angeles, to be sold on 08/25/2025 on NASDAQ. The filing shows an aggregate market value of $682,551.28 for the shares and reports 539,679,667 shares outstanding for the issuer. The securities to be sold were granted as restricted stock units (RSUs) from Microchip Technology on multiple dates: 07/30/2010 (2,047 shares), 08/18/2021 (1,674 shares), 08/22/2022 (1,296 shares), 08/19/2024 (2,492 shares), and 08/18/2025 (2,491 shares). The filer reports no securities sold in the past three months and includes the standard representation that no material nonpublic information is known.
Microchip Technology, Inc. (MCHP) Form 144 notifies the SEC of a proposed sale of 7,356 shares of common stock through Merrill in San Francisco, with an aggregate market value of $508,593.84 and an approximate sale date of 08/25/2025 on NASDAQ. The filer acquired 3,053 shares as RSUs from Microchip on 08/15/2025 and indicates payment in cash on that date. The filing also discloses a prior sale on 05/23/2025 of 2,015 shares generating $112,275.80 in gross proceeds. The notice includes the standard certification that the seller is unaware of undisclosed material adverse information.
Karen Marie Rapp, a Microchip Technology Incorporated (MCHP) non-employee director, had restricted stock units vest and received shares in August 2025. On 08/18/2025, 2,491 RSUs vested at an attributable value of $65.56 per share and those vested shares were delivered, leaving the reporting person with 11,137 shares directly beneficially owned after the transaction. An additional grant of 3,090 Restricted Stock Units was reported as of 08/19/2025 that will vest in full on the earlier of one day prior to the next annual meeting or one year from grant, contingent on continued service as a non-employee director.
Victor Peng, a Microchip Technology (MCHP) director, reported transactions on Form 4 dated 08/18/2025. He acquired 2,010 shares of Microchip common stock on 08/18/2025 at a price of $65.56 per share as restricted stock units vested and were delivered. After the transaction he beneficially owned 2,326 shares indirectly, with 2,280 held by The Peng Family Revocable Trust and 46 in an IRA. Separately, a grant of 3,090 restricted stock units remains outstanding and will vest either one day before the next annual meeting or one year from grant, contingent on continued service as a non-employee director.
Matthew W. Chapman, a non-employee director of Microchip Technology Incorporated (MCHP), reported stock-based transactions dated 08/18/2025. On that date 2,491 restricted stock units vested and were delivered, recorded as an acquisition at an attributed price of $65.56 per share, increasing his direct beneficial ownership to 40,665 shares. A separate grant of 3,090 restricted stock units was reported with a transaction date of 08/19/2025; each unit represents a contingent right to one share and will vest in full on the earlier of one day prior to the next annual meeting or one year from grant, subject to continued status as a non-employee director. The form was executed by an attorney-in-fact on 08/20/2025.
Microchip Technology Inc. (MCHP) director Richard B. Cassidy II had restricted stock units (RSUs) vest and received shares on August 18, 2025. 1,258 RSUs vested and were delivered as common stock to the reporting person, recorded as an acquisition at a price field of $65.56, resulting in 1,258 shares beneficially owned following the transaction. The filing also reports an additional grant of 3,090 RSUs dated August 19, 2025, which vest in full on the earlier of one day before the next annual meeting or one year from grant, subject to continued service as a non-employee director.
Microchip Technology Inc. (MCHP) Form 4: Non‑employee director Ellen Barker received 2,491 shares upon vesting of restricted stock units on 08/18/2025, recorded as an acquisition at a reported price of $65.56 per share, bringing her beneficial ownership to 3,797 shares. The filing also shows a grant of 3,090 restricted stock units on 08/19/2025 that are recorded as derivative awards and will convert into common stock when vested. The filing states each restricted stock unit represents the right to one share and explains vesting occurs in full on the earlier of one day before the next annual meeting or one year from grant, contingent on continued service as a non‑employee director.
Microchip Technology, Inc. held its annual meeting of stockholders on August 19, 2025, where shareholders elected individuals to serve on the company's Board of Directors until the next annual meeting or until their successors are duly elected and qualified. The filing contains the standard checkbox language relating to whether the registrant is an emerging growth company; the provided excerpt does not list the names of the directors elected, vote counts, or any additional meeting outcomes.